NEW YORK--(BUSINESS WIRE)--AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical company committed to developing novel precision oncology therapies, together with Innovent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results